School News

9/9/19

A new drug discovered through a research collaboration between the University at Buffalo and Tetra Therapeutics may protect against memory loss, nerve damage and other symptoms of Alzheimer’s disease.

9/3/19
BUFFALO, N.Y.—Joseph Balthasar, professor of pharmaceutical sciences, was appointed Executive Director of Research Initiatives in the Office of the Vice President for Research and Economic Development at the University at Buffalo.
8/21/19

One hundred and thirty-three students will take their first step toward becoming pharmacists when they participate in the University at Buffalo School of Pharmacy and Pharmaceutical Sciences Annual White Coat Ceremony.

8/16/19
BUFFALO, N.Y. — The University at Buffalo Center for Protein Therapeutics has awarded over $1 million for research projects to advance the development of next-generation protein drugs for the 2019-2020 academic year.
8/15/19

Higher levels of blood high-density lipoprotein (HDL) — or good cholesterol — may improve fatigue in multiple sclerosis patients, according to a new UB-led study.

8/15/19
The University at Buffalo School of Pharmacy and Pharmaceutical Sciences now offers an innovative new master’s degree program in Pharmacometrics and Personalized Pharmacotherapy.
8/2/19
BUFFALO, NY--The University at Buffalo School of Pharmacy and Pharmaceutical Sciences hosted students, scientists and researchers from around the world for two pharmaceutical sciences meetings: the Quantitative Systems Pharmacology Symposium and the Great Lakes Symposium.
7/31/19
William Jusko, SUNY Distinguished Professor of Pharmaceutical Sciences, has received a five-year MIRA award totaling nearly $2.9 million for research entitled “Mechanistic Pharmacokinetics and Pharmacodynamics.”